News-Medical.Net on MSN
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not ...
Investing.com -- Bausch Health (NYSE:BHC) stock plunged 8% Friday morning after the company announced disappointing results ...
InvestorsHub on MSN
Bausch Health shares slide after phase 3 liver disorder study misses goal
Shares of Bausch Health (NYSE:BHC) dropped about 8% in early trading on Friday after the company disclosed unsuccessful ...
News-Medical.Net on MSN
Unraveling liver injury mechanisms in familial hypobetalipoproteinemia
Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total ...
Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...
Branched-chain amino acids (BCAAs) may also be used as part of treatment, but they work in a different way. People with cirrhosis often have low levels of BCAAs. Taking BCAA supplements can help ...
Chronic hepatic encephalopathy (CHE) is a serious neurological complication linked to chronic liver diseases. Particularly ...
When colon cancer spreads to the liver from another part of the body, doctors have many ways to treat it. Hepatic artery infusion (HAI) therapy is a focused option that delivers high-dose chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results